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Sirt1 is an NAD-dependent, class III deacetylase that functions as a cellular energy sensor. In addition
to its well-characterized effects in peripheral tissues, emerging evidence suggests that neuronal Sirt1
activity plays a role in the central regulation of energy balance and glucosemetabolism. In this study, we
generated mice expressing an enzymatically inactive form (N-MUT) or wild-type (WT) SIRT1 (N-OX) in
mature neurons. N-OX male and female mice had impaired glucose tolerance, and N-MUT female, but
not male, mice had improved glucose tolerance compared with that of WT littermates. Furthermore,
glucose tolerance was improved in all mice with caloric restriction (CR) but was greater in the N-OX
mice, who had better glucose tolerance than their littermates. At the reproductive level, N-OX females
had impaired estrous cycles, with increased cycle length and more time in estrus. LH and progesterone
surges were absent on the evening of proestrus in the N-OX mice, suggesting a defect in spontaneous
ovulation, which was confirmed by the ovarian histology revealing fewer corpora lutea. Despite this
defect, the mice were still fertile when mated to WT mice on the day of proestrus, indicating that the
mice could respond to normal pheromonal or environmental cues.When subjected to CR, theN-OXmice
went into diestrus arrest earlier than their littermates. Together, these results suggested that the
overexpression of SIRT1 rendered the mice more sensitive to the metabolic improvements and sup-
pression of reproductive cycles by CR, which was independent of circadian rhythms.
Copyright © 2019 Endocrine Society
This article has been published under the terms of the Creative Commons Attribution Non-
Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Sirtuin 1 (SIRT1) was first identified as a mammalian homolog of the yeast silent information
regulator 2 (Sir2) protein, which is essential for lifespan extension due to caloric restriction(CR).
The sirtuins are class III histone deacetylases that requireNAD+ for enzyme activity [1] and these
enzymes function as cellular energy sensors sensitive to the intracellular NAD+/NADH ratio.
SIRT1 is activated during fasting to increase fatty acid oxidation and gluconeogenesis, and
suppress insulin secretion, insulin action, and adipogenesis [2–4]. Conversely, SIRT1 is reduced
in adipose tissue by overnutrition in mouse models, human obesity, and in many brain regions
[5–8]. Consequently, global transgenic overexpression improves glucose tolerance and insulin
sensitivity even on a low-fat diet, because of increased brownadipose tissue activity, enhancedb3
Abbreviations: 12:12 LD, cycle of 12 hours of light and 12 hours of dark; AgRP, Agouti-related peptide; CR, caloric restriction; GC,
granulosa cell; KO, knockout; N-OX, wild-type SIRT1; N-MUT, enzymatically inactive form of SIRT1; Npy, neuropeptide Y; POMC,
pro-opiomelanocortin; qPCR, quantitative PCR; SCN, suprachiasmatic nucleus; Sirt1, sirtuin 1; Syn-cre, Syntaxin1 promoter–
controlled cre recombinase expression; WT, wild type.
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adrenergic stimulation, and reduced inflammation [9–11]. The global knockout (KO) is difficult to
interpret because most mice die in utero or perinatally [12–14], and those that survive on an
outbred background are runted [14]. Study findings showed the global inactivation of the
acetylase activity by deletion of exon 4 led to a similar phenotype with embryonic lethality, but
the few surviving animals had higher triglyceride levels, higher levels of fatty acid release from
adipose tissue, and greater hepatic steatosis on a high-fat diet [15, 16]. Similarly, introduction
of a pointmutation (H355Y) that inactivates the enzymeactivity caused runting, elevated oxygen
consumption, and male infertility [17], and increased the susceptibility to high-fat diet–induced
metabolic dysfunction [18].
SIRT1 has also been reported to have tissue-specific effects. Forced reduction of Sirt1 in
white adipose tissue by antisense oligonucleotides or conditional KO reduced body weight
and white adipose tissue weight but increased macrophage infiltration, whereas over-
expression prevents these effects [19]. Loss of SIRT1 in skeletal muscle reduces insulin
sensitivity during CR [20]. Deletion in hepatocytes causes increased hepatic glucose pro-
duction, fasting hyperglycemia, greater fasting-induced steatosis, and the development of
late-onset obesity [16, 21–23]. A transgenic overexpressing line that uses the entire Sirt1
gene did notmimic intermittent fasting, despite enhancing brown adipose tissue function and
protecting against high-fat diet–induced glucose intolerance [10, 11, 24–26].
Conflicting results have been obtained at the reproductive level. One study reported that the
few survivingmalemice from the global KO studies were infertile, as are themajority of female
mice [14], but another study found that mice could be fertile [27, 28]. SIRT1 is expressed in
spermatogonia and has been implicated in germ cell development in males [29, 30]. In the
ovary, SIRT1 is expressed in large follicles, particularly in the oocyte and granulosa cells. Loss
of SIRT1 causes small ovaries with early-stage follicular development but no evidence of
ovulation [14, 31]. SIRT1 modulates androgen receptor and estrogen receptor-a function that
may underlie some of the reproductive effects [32–35]. SIRT1 thus has beneficial effects in
multiple tissues that ameliorate insulin resistance and support reproduction.
SIRT1 also pays a role in the central nervous system, but the results are less clear. Many
studies have focused on the role of SIRT1 to prevent neuronal injury in ischemic stroke, Alz-
heimer’s disease, brain injury, and other models of neurodegeneration, potentially by reducing
neuroinflammation [36–38]. SIRT1 also modulates cognitive function, synaptic plasticity, and
learning [39]. Brain-specific deletion of Sirt1 using Nestin-cre decreases monoamine oxidase
activity, increases serotonin levels, and decreases anxiety and depressive-like behavior [40, 41].
As in the periphery, SIRT1 expression and activity increase in the hypothalamus under fasting
conditions, to regulate food intake and energy expenditure [42–44]. Some of these effects may be
mediated by different neuronal populations, because deletion ofSirt1 in Pomc neurons decreases
energy expenditure and increases susceptibility to diet-induced obesity inmice [45], but deletion
of Sirt1 in Agouti-related peptide (AgRP) neurons has the opposite effect and decreases food
intake and body weight [46, 47]. Mice lacking Sirt1 in Sf1-expressing neurons have increased
susceptibility to diet-induced obesity and insulin resistance similar to the Pomc neuron KO,
primarily due to decreased energy expenditure and skeletal muscle insulin sensitivity, but the
mice are fertile, and transgenic overexpression prevents these effects [48].
Thus, it appears that SIRT1may play distinctive and sometimes even opposing roles in energy
balance and reproduction through different neuronal populations. Interpretation of the studies is
complicated by the different approaches used to delete the gene. Some studies use deletion of exon
4, which encodes the deacetylase domain, to create a mutant protein lacking enzyme activity, but
other studies delete exons 2 and 3, resulting in the introduction of a premature termination codon
so no protein is produced. The widespread expression of SIRT1 in the periphery and central
nervous systemmakes it difficult to assign a function for SIRT1 in a particular process; therefore,
we have chosen to create neuron-specific genetic modifications using transgenic cre recombinase
that is expressed in a wide range of mature neurons. Using this approach, we recently reported
that loss of SIRT1 enzymatic activity in neurons in male mice reduced fasting and glucose-
stimulated insulin levels while maintaining normoglycemia, suggesting increased insulin
sensitivity [37]. In the current study, we characterized male and female mice expressing this
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enzymatically dead SIRT1 mutant, or conversely, conditionally overexpressing the wild-type
(WT)SIRT1protein, inmature neuronsusing synapsin-cre to distinguish peripheral fromcentral
effects on metabolism and reproduction.
1. Methods
A. Animals
Mice with cre recombinase expression under control of the neuron-specific Syntaxin1 pro-
moter (Syn-cre) [49] were mated with mice with an exon 4 floxed Sirt1 allele or a floxed-STOP
Sirt1 allele [50]. Expression of cre deletes exon 4 of Sirt1 that encodes the acetylase domain,
thus creating a functionally inactive mutant (N-MUT; i.e., an enzymatically inactive form of
SIRT1) from the floxed allele, or causes overexpression of wild-type SIRT1 by deletion of the
transcriptional STOP sequence from the flox-STOP allele (N-OX; i.e., WT SIRT1). The cre
driver was maintained on the female side, because the Syn-cre transgene is expressed in the
testis [51]. Syn-cre mice express the cre transgene as early as embryonic day 12.5 in dif-
ferentiated neurons throughout the brain [49].
Homozygous flox/cre- and heterozygous flox/cre- littermates from either the N-MUT or N-OX
breeding pairs were used as WT control mice. In most experiments, no statistical difference was
observed between theWTcontrolmice from theN-MUTorN-OXbreeding pairs, so the datawere
combined into a singleWTgroup.Occasionally, statistically significant differenceswere observed
between the control groups, in which case the data were analyzed against each separate control
group.Micewere housedunder a 12-hour light, 12-hour dark cycle (12:12LD). Bodyweightswere
recorded weekly out to 90 days of age for both sexes. Males and females had access to standard
chow and water ad libitum. Mouse procedures conformed to the Guide for Care and Use of
LaboratoryAnimals of theUSNational Institutes ofHealth andwere approved by theUniversity
of California, San Diego, Animal Subjects Committee.
B. Caloric Restriction
At 12 weeks of age, food intake by cohorts of female and male mice was measured for 2 weeks
to assess ad libitum food intake. For the graded CR,mice were provided with 90% of prior food
intake for week 1, then 80% for week 2, 70% for week 3, and then maintained at 60% of
original intake for weeks 4 through 6. Body weight was measured weekly. The study was
divided into four phases: before, stage 1 (weeks 1 and 2: 10% to 20% CR), stage 2 (weeks 3 and
4: 30% to 40% CR), and stage 3 (weeks 5 and 6: 40% CR). Estrous cycles were monitored in
femalemice by vaginal cytology for the entire 8 weeks. A cycle was defined as a day of diestrus
or metestrus, followed by a day of proestrus, then a day of estrus. The length of the cycle was
defined as the number of days between successive days of proestrus in normal diestrus-
proestrus-estrus cycles
C. Puberty Onset and Fertility Assessment
Male and female pups were weaned at 21 days of age. Female pups were checked for vaginal
opening as a sign of onset of puberty and monitored for first estrous. For fertility assessment,
N-MUT, N-OX, or WT female mice were paired on the day of proestrus with known WT male
breeders. The number of days to observable vaginal plugs, the number days to the first litter,
and average number of pups born were recorded.
D. Tissue Collection and Histology
Testes, ovaries, brain, pituitary glands, and other tissues were collected after euthanasia for
histology and for RNA extraction. Testes were fixed in Bouin’s solution for 6 hours and ovaries
in formalin for 24 hours, followed by washing in 70% ethanol. Paraffin-embedded sections
(5 mm) were cut, dewaxed, and stained with hematoxylin and eosin. Follicle number and
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stage, and corpora lutea number were counted in three to five sections from ovaries from four
to five mice per group; counts are presented as the mean number per ovary [52]. Follicle
stages were defined as follows: primary: having a single layer of cuboidal granulosa cells
(GCs); secondary: having two or more layers of cuboidal GCs but no antrum; early antral:
having small patches of clear space between GCs; antral: having clearly defined antrum; and
atretic: having irregular oocyte morphology. Ovarian sections examined were separated by
50 mm. Images were scanned using an Aperio ImageScope and analyzed using the Image-
scope software (Leica, Buffalo Grove, IL).
E. Gene Expression
Total RNA was extracted from the tissues using RNAbee (Tel-Test, Friendswood, TX) fol-
lowing the manufacturer’s instructions. First-strand cDNA was synthesized using a high
capacity cDNA synthesis kit (Applied Biosystems, Waltham, MA). Targeted quantitative
PCR (qPCR) assays were run in 20-mL triplicate reactions on a MJ Research Chromo4 in-
strument using iTaq SYBR Green Supermix (Bio-Rad, Hercules, CA). For gene expression
assays using 7 nL microfluidic arrays (Fluidigm, San Francisco, CA), mRNA was extracted
using RNAbee as before, but it was further purified using RNA purification kits from
QIAGEN (Germantown, MD) or Macherey-Nagel (Bethlehem, PA), according to manufac-
turer’s instructions. Custom qPCR primers for a panel of targets were designed and syn-
thesized by Fluidigm for their BioMark HD System. Gene expression levels were calculated
after normalization to the housekeeping genes m36B4 or Gapdh using the comparative
threshold cycle method and expressed as relative mRNA levels compared with the control.
Primers are listed in an online repository [53].
F. Gonadotropin Measurements
Blood was collected from the tail vein of males and from females at diestrus and proestrus,
and plasma was prepared. Plasma LH and FSH levels were measured by Luminex assay
(catalog no. RPT86K;Millipore, Bedford,MA). Sensitivity of the assay for LH is 4.9 pg/mL and
for FSH, 47.7 pg/mL, with an intra-assay coefficient of variation of 15%. For the GnRH
stimulation test, tail-vein blood was collected before and 10 minutes after IP injection of
1 mg/kg GnRH (Sigma-Aldrich, St. Louis, MO), and gonadotropins were measured.
G. Intraperitoneal Glucose Tolerance and Insulin Tolerance Tests
Micewere subjected to IP glucose and insulin tolerance tests.Micewere fasted for 6 hours and
then injected IP with glucose (1 g/kg body weight) or insulin (0.4 U/kg body weight). Tail-vein
blood glucose level was measured at 0, 15, 30, 45, 60, 90, and 120 minutes after injection
using a glucose meter (OneTouch Ultra; Bayer Healthcare, Tarrytown, NY). Glucose and
insulin tolerance assays were performed for mice receiving normal chow and during the last
week of 40% food restriction.
H. Insulin, Leptin, and Steroid Measurements
Animals were fasted for 6 hours. Glucose level was measured with a glucose meter, blood was
collected from the tail vein, and plasma was obtained. Fasting insulin and leptin levels were
measured using the Mouse Metabolic Kit (catalog no. K15124C-2; Meso Scale Discovery,
Rockville, MD). Sensitivity of the assay was as follows: leptin: 43 pg/mL; insulin: 15 pg/mL;
coefficients of variance: 6% and 12%, respectively. Estrogen, progesterone, and testosterone
levels were measured using a Custom Steroid Hormone Panel Kit (Meso Scale Discovery)
Sensitivity of the assay was as follows: estradiol 5 pg/mL; progesterone 70 pg/mL; testos-
terone 20 pg/mL; coefficients of variance: 7%, 15%, and 22% respectively.
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I. Metabolic Assessment
Six mice per group (i.e., WT and N-OX), matched for body weight, were individually housed
in a 12-chamber Clinical Laboratory Animal Monitoring System (Columbus Instruments,
Columbus, OH) with controlled temperature, light, and feeding. Oxygen uptake, carbon
dioxide output, respiratory exchange ratio, horizontal and vertical ambulatory movement,
and feeding and drinking per 13-minute intervals were measured over 3 days. Data from the
first 12 hours during day-1 acclimation were excluded from the analysis.
J. Circadian Activity
Female andmalemicewere raisedunder a12:12LDphotoperioduntil 3months of age. Thereafter,
mice were singly housed in standard shoebox cages equipped with running wheels (13-cm dia-
meter). Cagesweremaintained in light-tight secondary enclosureswith programmable fluorescent
lighting for a three-phase assessment of circadian entrainment and free-running behavior con-
ducted over ;6 weeks. Initially, entrained behavior of each mouse was assessed over 2 weeks
under the 12:12 LD. Thereafter, monitoring continued for an additional 2 weeks in a skeleton
photoperiod consisting of two 1-hour light pulses coinciding with the first and last hours of the 12-
hour light phase. This protocol removes potential masking effects of bright light on locomotor
activity. Finally, endogenous circadian rhythmicity was assessed under continuous darkness over
7 to 10 days. A total of 48 mice were assessed in four cohorts.
Wheel turns were recorded and compiled into 6-minute bins. Data were analyzed offline using
the Clocklab (Actimetrics, Wilmette, IL) suite of Matlab plugins (Mathworks, Natick, MA). For
each animal, the following variableswere calculated in light/dark and skeleton photoperiods over
final 7-day spans of each photoperiod condition. The proper phasing of activity was assessed by
calculating the timing of activity onset and offset, defined as the first and last time that the 7-day
average activity profile rose above and below the daily mean, respectively. From these data were
derived the phase angle of entrainment and the duration of elevated nighttime activity. Dis-
ruption of circadian timing was additionally assessed by calculating the proportion of activity
intruding into the daytime (i.e., the central 8 hours of the light phase or skeleton daytime).
Rhythm robustness was assessed by calculating themaximum amplitude of the x2 periodogram.
In the first 7 days of continuous darkness, the free-running period was estimated as the value
with the highest amplitude in the x2 periodogram and as the best-fit linear regression line
through identified activity onsets. These methods yielded comparable estimates and only the
former is reported here. Individually identified activity onsets were additionally used to de-
termine the cycle-to-cycle variability in free-running activity onset. In all phases, the total
amount of wheel-running activity without respect to its timing was also assessed.
All data were analyzed with four-way ANOVA with cohort, strain (OX vs MUT), Cre
genotype (Cre+ or Cre-), and sex as between-subject factors. For phenotype screening, a was
set initially at 0.05 without correction for multiple comparisons.
K. Statistical Analysis
Data were analyzed by ANOVA or Student t test, as appropriate, using GraphPad Prism
(GraphPad, La Jolla, CA) or in R (https://www.r-project.org/). Pairwise comparisons were
performed using Tukey post hoc tests after the ANOVA. Results are expressed as mean6 SE
and considered significant at P , 0.05. Supplemental data are provided in an online
repository [53].
2. Results
A. Neuronal SIRT1 Overexpression Caused Glucose Intolerance
To test the role of neuronal SIRT1 in metabolic and reproductive regulation, we generatedN-
MUT [37] andN-OX mice. Assessment of Sirt1mRNA expression in whole brains fromN-OX
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mice indicated that the gene is overexpressed approximately 2.5-fold [53]. The body weights
ofmalemice indicated a significant difference with genotype over the first 3months, although
no significant difference was observed at 8 to 9 months of age (Fig. 1A), and the female mice
did not differ appreciably in body weight (Fig. 1B). Food intake did not differ inmalemice, but
the female N-MUT mice ate significantly more (Fig. 1G and 1H) despite having equivalent
body weight. The male N-OX mice were significantly glucose intolerant (Fig. 1C), unlike the
N-MUTmice, as we have previously reported [37]. Consistent with the male mice, the female
N-OX mice also were glucose intolerant, but the N-MUT mice had significantly improved
glucose tolerance compared withWT controls (Fig. 1D). Neither theN-MUT norN-OX groups
showed altered insulin tolerance inmalemice, but the femaleN-MUTmice were significantly
more insulin sensitive than WT or N-OX littermates (Fig. 1E and 1F). Fasting blood glucose
and insulin levels and homeostatic model of assessment of insulin resistance were compa-
rable between the groups and sexes (Fig. 1I–1L; and in a supplemental figure provided in an
online repository [53]), but leptin levels were significantly lower in N-OX mice for both sexes
(Fig. 1M and 1N).
B. SIRT1 Overexpression Impaired Estrous Cycles
NeitherN-MUTnorN-OX femalemice differed in the day of vaginal opening (Fig. 2A), but the
N-OX mice reached first estrous slightly earlier (Fig. 2B), indicating that all genotypes went
through puberty normally. Assessment of the number of estrous cycles over 6 weeks after the
onset of estrous cycles showed thatN-OXmice had fewer cycles (Fig. 2C), and analysis of cycle
length indicated thatN-OX mice tended to have a slightly longer mean cycle length (6.6 days
forN-MUT, 6.5 days for WT, and 7.8 days forN-OX; Fig. 2D) with more extended cycles (Fig.
2E). TheN-OXmice had significantlymore days of estrus and fewer days of diestrus (Fig. 2F).
Representative cyclegrams are provided in an online repository [53]. No differences in FSH
level were observed in N-OX mice at diestrus, the morning or evening of proestrus, or on
estrus, but the WTmice had the expected higher FSH levels during late proestrus and estrus
(Fig. 2G). LH levels were elevated at diestrus in N-MUT mice, but no differences were ob-
served in early proestrus or on estrus (Fig. 2H). LH levels during late proestrus showed LH
surges inN-MUT (n = 2 of 8) and WT (n = 8 of 16) mice, but no surges were observed inN-OX
mice (Fig. 2I).
Measurement of progesterone levels confirmed that N-OX mice had not ovulated, com-
pared with WTmice (Fig. 2J). These results suggested that spontaneous LH surges might be
impaired in theN-OXmice, so we tested fertility directly by pairing female mice on proestrus
with knownmaleWT breeders. The number of days until the observation of vaginal plugs, the
number of days until first litter, and the litter size did not show a difference associated with
genotype (Fig. 1K), indicating the mice were fertile and could ovulate given normal envi-
ronmental cues. Comparison of ovarian histology (Fig. 3A) showed that N-OX ovaries were
smaller (Fig. 3B) and did not show a difference in follicle development (Fig. 3C), but corpora
lutea were significantly reduced in the N-OX mice, consistent with the decreased LH surges
and progesterone levels (Fig. 3D). Male mice were not studied reproductively, because the
synapsin-cre is expressed in the testis [51].
C. Mice With Neuronal SIRT1 Overexpression Were More Sensitive to Improvements in
Glucose Tolerance and Estrous Cycle Arrest, Due to CR
We then tested whether neuronal SIRT1 might alter the response to CR. To avoid the in-
duction of an adrenal stress response due to a rapid reduction in food intake, we used a
gradual 10% reduction of food intake over 4 weeks, then maintained the mice for an addi-
tional 2 weeks at 40% CR. Assessment of glucose tolerance during the last week showed that
the N-OX mice had improved glucose tolerance (Fig. 4A). Insulin levels were higher in WT
and N-OX mice during the initial stage of CR, consistent with fasting-induced insulin re-
sistance, but then levels returned to normal (Fig. 4B). In contrast, leptin levels decreased
432 | Journal of the Endocrine Society | doi: 10.1210/js.2018-00318
doi: 10.1210/js.2018-00318 | Journal of the Endocrine Society | 433
progressively during CR (Fig. 4C) and theN-OX mice had consistently lower leptin levels, as
we had seen earlier (Fig. 1M and 1N).
Estrous cycles were assessed in the femalemice during the entire period of CR.N-MUTmice
had the same response asWTmice: a gradual increase in the days of diestrus and a decrease in
the days at proestrus and estrus (Fig. 5A). In contrast, the N-OX mice had fewer days at
diestrus before CR, did not respond to the 10% to 20% CR, but showed a steep increase in the
days of diestrus during the 30% to 40% CR such that all mice were in permanent diestrus by
40% CR. This was confirmed by determining the relative frequency of diestrus arrest at each
CR stage for each genotype [53]. The WT andN-MUTmice had the highest frequency of arrest
at 40% CR, but the N-OX mice had the highest frequency of arrest at 20% to 30% CR. Un-
expectedly, we did not observe a significant decrease in LH levels during CR in any genotype
(Fig. 5B), but we did observed an increase in FSH levels even at the lowest level of CR (Fig. 5C).
Interestingly, this response was sexually dimorphic, because FSH levels decreased in male
mice on CR, but LH levels did not change [53]. Inspection of ovarian histology at euthanasia
showed that all mice had ceased cycling, because no corpora luteawere observed [53]. At time of
euthanasia, estrogen levels were slightly higher in mice under CR but were significantly lower
in WT mice than N-MUT and N-OX mice (Fig. 5D). Progesterone levels increased during CR
(Fig. 5E); testosterone levels increased with CR, but there was also a genotype effect, with N-
MUT mice having significantly higher levels of testosterone (Fig. 5F).
D. Altered Hypothalamic Gene Expression in CR Mice
RNAwas extracted from hypothalami and pituitaries of female mice euthanized at the end of
CR. TheN-OX mice had approximately twofold overexpression of Sirt1 by qPCR (Fig. 6A), as
observed before (Fig. 1). Expression of neuropeptide Y (Npy),Pomc, andAgrp that control food
intake and energy expenditure was increased in the N-OX mice, but the cocaine and
amphetamine-regulated transcript (Cart) was unchanged (Fig. 6A). Expression of the re-
productive neuropeptides gonadotropin-releasing hormone 1 (Gnrh1), and the RF-amide
related peptide 3 precursor gene (Npvf) were significantly altered, but expression of the
kisspeptin gene (Kiss1) was unchanged (Fig. 6A). Neuropeptide receptor gene expression did
Figure 1. Neuronal SIRT1 caused glucose intolerance in mice. Data for N-MUT mice are
shown in red, in white for WT littermates, and green for N-OX mice in green. For (A–D),
Two-way ANOVA indicated significant genotype and time effects (P , 0.0001) but no
interaction. (A) Body weights for male mice from 3 to 13 wk of age (n = 13 for N-MUT; n =
48 for WT; n = 24 for N-OX). Inset shows final body weight at 8 to 9 mo. (B) Body weights
for female mice from 3 to 13 wk of age (n = 10 for N-MUT; n = 44 for WT; n = 20 for N-OX).
Inset shows final body weight at 8 to 9 mo. (C) Glucose tolerance testing in male mice at
3 mo of age (n = 8 for N-OX; n = 16 for WT; n = 4 for N-MUT). Two-way ANOVA indicated
significant interaction effect (P = 0.005). Inset shows AUC data. (D) Glucose tolerance testing
in female mice at 3 mo of age (n = 9 for N-OX; n = 16 for WT; n = 6 for N-MUT). Inset shows
AUC data. (E) Insulin tolerance testing in male mice at 3 mo of age (n = 9 for N-OX; n = 16
for WT; n = 6 for N-MUT). (F) Insulin tolerance testing in female mice at 3 mo of age (n = 10
for N-OX; n = 16 for WT; n = 6 for N-MUT). (E, F) Two-way ANOVA indicated significant
genotype and time effects (P , 0.001 and P , 0.0001, respectively) but no interaction. (G)
Daily food intake over 10 wk for male mice (n = 3 for N-MUT; n = 12 for WT; n = 4 for N-
OX). (H) Daily food intake over 10 wk for female mice (n = 6 for N-MUT; n = 11 for WT; n =
5 for N-OX). (I) Fasting blood glucose data of male mice (n = 17 for N-OX; n = 32 for WT; n =
8 for N-MUT). (J) Fasting blood glucose data of female mice (n = 20 for N-OX; n = 32 for WT;
n = 4 for N-MUT). (K) Fasting insulin data of male mice (n = 6 for N-MUT; n = 14 for WT;
n = 6 for N-OX). (L) Fasting insulin data of female mice (n = 6 for N-MUT; n = 12 for WT;
n = 6 for N-OX). (M) Fasting leptin data of male mice (n = 6 for N-MUT; n = 14 for WT; n =
6 for N-OX). (N) Fasting leptin data of female mice (n = 6 for N-MUT; n = 12 for WT; n = 6
for N-OX). Data are reported as mean 6 SEM. *P , 0.05, **P , 0.01, *P , 0.001, and
****P , 0.0001 vs WT or as indicated. AUC, area under the curve.
434 | Journal of the Endocrine Society | doi: 10.1210/js.2018-00318
Figure 2. Neuronal SIRT1 regulated reproduction in female mice. Data for N-MUT mice are
shown in red, in white for WT littermates, and green for N-OX mice in green. (A) Day of
vaginal opening (n = 8 for N-MUT; n = 40 for WT; n = 18 for N-OX). (B) Day of first estrous
(n = 8 for N-MUT; n = 41 for WT; n = 21 for N-OX). (C) Number of estrous cycles by vaginal
lavage over 6 wk (n = 6 for N-MUT; n = 11 for WT; n = 5 for N-OX). (D) Cycle length during
the 6 wk (n = 44 for N-MUT; n = 74 for WT; n = 19 for N-OX). (E) Relative-frequency
histogram of cycle lengths. (F) Percentage of d spent in each stage of the estrous cycle during
the 6-wk cycling (n = 6 for N-MUT; n = 11 for WT; n = 5 for N-OX). Two-way ANOVA
indicated significant stage effect (P , 0.0001) and significant interaction of stage and
genotype (P , 0.0001). (G) FSH levels during diestrus, the morning of proestrus (Pro-AM),
the afternoon of proestrus (Pro-PM), and the morning of estrus (n = 8 for N-MUT; n = 16 for
WT; n = 8 for N-OX). Two-way ANOVA indicated significant stage effect (P = 0.015) and
significant interaction of stage and genotype (P = 0.013). (H) LH levels during diestrus, the
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not change with genotype [53]. The same alterations in hypothalamic gene expressionwere not
seen in male mice [53]. Assessment of pituitary gene expression in female mice indicated a
threefold increase in Fshb gene expression in N-OX mice, an increase in the glycoprotein
hormonea gene (Cga) in theN-MUTmice, and decreases in growth hormone (Gh) and pituitary
adenylate-cyclase activating peptide (Adcyap1) gene expression in N-MUT mice (Fig. 6B).
E. Altered Dark-Phase Activity in Mice With SIRT1 Overexpression
TheN-OXmice were glucose intolerant; thus, we subjectedN-OX andWTmice to ametabolic
assessment with continuous monitoring over 3 days. The N-OX mice had greater diurnal
morning of proestrus, and the morning of estrus (n = 8 for N-MUT; n = 16 for WT; n = 8 for
N-OX). Two-way ANOVA indicated significant stage effect (P = 0.013) but no interaction of
stage and genotype. (I) LH levels during the afternoon of proestrus (n = 8 for N-MUT; n = 16
for WT; n = 8 for N-OX). Proestrus LH values did not follow a normal distribution, so N-OX
mice had significantly lower LH levels than did WT mice by Kruskal-Wallis test (P = 0.033).
(J) Progesterone levels during the afternoon of proestrus (n = 7 for WT; n = 7 for N-OX). (K)
Days to plug, days to first litter, and litter size during fertility test (n = 3 for N-MUT; n = 11
for WT; n = 6 for N-OX). Data are reported as mean 6 SEM. *P , 0.05, **P , 0.01, *P ,
0.001, ****P , 0.0001 vs WT or as indicated.
Figure 3. Overexpression of SIRT1 impaired ovulation. Data for N-MUT mice are shown
in red, in white for WT littermates, and green for N-OX mice in green.. (A) Ovarian
morphology. Representative hematoxylin- and eosin-stained sections of ovaries obtained at
euthanasia. (B) Quantification of ovarian cross-sectional area for N-MUT (n = 12), WT (n =
15), and N-OX (n = 8) ovaries. *P , 0.05 vs N-MUT. (C) Quantification of follicle stage.
Percentage of follicles at each stage for N-MUT (n = 6), WT (n = 9), and N-OX (n = 4) mice.
(D) Quantification of CL for N-MUT (n = 6), WT (n = 9), and N-OX (n = 4) mice. *P , 0.05 vs
WT. Data are reported as mean 6 SEM. *Significant difference by post hoc testing.
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Figure 4. Overexpression of SIRT1 enhanced the metabolic response to CR. Data for N-
MUT mice are shown in red, in white for WT littermates, and green for N-OX mice in green.
(A) Glucose tolerance test conducted after CR (n = 8 for N-OX; n = 17 for WT; n = 6 for N-
MUT; n = 20 males; n = 11 females). Two-way ANOVA indicated a significant time effect
(P , 0.0001) and time-genotype interaction (P = 0.0025). (B) Fasting insulin levels during CR
(n = 14 for N-MUT; n = 26 for WT; n = 12 for N-OX; n = 28 males; n = 24 females). (C)
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changes in ambulatory and rearing activity (Fig. 7A and 7B). The onset of activity at the start
of the dark phase was similar, but the N-OX mice were more active and sustained that
activity throughout the entire dark phase, whereas the WT mice reduced activity in an-
ticipation of the light phase. The difference in average activity level between the dark and
light phases was also increased [53].
There was no significant difference in body weight between genotypes at the end of the
assessment. Oxygen consumption was also altered, with lower consumption at the start of
dark phase but higher consumption at the end of the dark phase (Fig. 7C), and there was a
genotype effect in the respiratory exchange ratio, with greater lipid oxidative metabolism
during the light phase in the N-OX mice, consistent with greater sensitivity to fasting (Fig.
7D). There was diurnal variation with food intake but no genotype effect, whereas there was a
weak genotype effect with water intake (Fig. 7E and 7F). The expected diurnal variation
occurred with heat production and cage temperature, but there was no genotype effect (Fig.
7G and 7H).
F. Unaltered Circadian Activity in Mice With Lack or Overexpression of Neuronal SIRT1
SIRT1 has been implicated in the regulation of the central circadian clock via deacetylation of
PGC-1a [54]. In 12:12 LD, femalemice hadmore robust circadian rhythms (P, 0.05) than did
male mice [53] and had higher total and average activity counts (P , 0.001). Mice initiated
wheel running shortly after lights off, according to the expected nocturnal pattern, and had
the same period and activity onset and offset. The sex difference in rhythm robustness,
average counts, and total counts persisted in the skeleton photoperiods (P , 0.05, 0.01, and
0.01 respectively). There were small genotype differences in rhythm robustness, 8-hour
daytime counts, activity onset, and activity period, but none reached significance. In con-
tinuous darkness, a strain effect was associated with period (P , 0.05), with all MUT mice
having a slightly shorter period, and a genotype effectwas associatedwith rhythm robustness (P,
0.05), with theMUT genotype having greater robustness. In summary, SIRT1-overexpressing and
mutant mice generated species-typical circadian locomotor activity rhythms, with the major
difference being female mice were more active and had more robust rhythms.
3. Discussion
Previously, loss of SIRT1 enzyme activity in neurons did not alter glucosemetabolism inmale
mice but increased insulin sensitivity in the brain and periphery, and partially protectedmice
from high-fat diet–induced obesity [37]. Here, we studied the same N-MUT mice but also
studied the effect of overexpression of wild-type SIRT1 in neurons. In male mice, we observed
that the N-MUT did not alter glucose tolerance as before, but we did observe decreased
glucose tolerance in N-OX mice, which is consistent with the previous report on the N-MUT
mice [37]. In contrast, N-MUT female mice had an improvement in glucose tolerance,
whereas glucose intolerance was impaired in female N-OX mice. Unlike in the male mice,
insulin sensitivity was slightly increased in the female N-MUT mice by insulin tolerance
tests, but fasting blood glucose and insulin levels were not changed; consequently, the ho-
meostaticmodel of assessment of insulin resistancewas not significantly different. SIRT1 has
been implicated in the response to food restriction; therefore, themice were challenged with a
gradual but progressive CR down to 60% of their normal food intake over 6 weeks. All mice
had improved glucose tolerance, and the N-OX mice had better glucose tolerance than their
littermates after CR, instead of worse glucose tolerance as had been seen formice receiving ad
Fasting leptin levels during CR (n = 14 for N-MUT; n = 26 for WT; n = 12 for N-OX; n = 28
males; n = 24 females). Two-way ANOVA indicated a significant genotype effect (P ,
0.0001). Data are reported as mean 6 SEM. *P , 0.05, **P , 0.01 among N-OX and WT
and N-MUT, or as indicated, from post hoc testing. AF, antral follicle; CL, corpus luteum.
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Figure 5. Overexpression of SIRT1 enhanced the reproductive response to CR. Data for N-
MUT mice are shown in red, in white for WT littermates, and green for N-OX mice in green.
Estrous cycles were assessed by vaginal lavage in female mice during the 8 wk of CR. Data
are reported as mean 6 SEM. (A) Average number of d spent in met/diestrus, proestrus, or
estrus during the four 2-wk stages of increasing CR for each genotype of the estrous cycle
during the 6-wk cycling (n = 6 for N-MUT; n = 14 for WT; n = 5 for N-OX). Two-way ANOVA
indicated a significant CR effect (P , 0.0001) and significant interaction of CR and genotype
(P = 0.003) for met/diestrus, a CR effect (P , 0.0001) for proestrus; and a genotype effect
(P = 0.017), a CR effect (P , 0.0001), and a significant interaction of CR and genotype (P =
0.011) for estrus. (B) LH levels during the four stages of CR (n = 6 for N-MUT; n = 12 for
WT; n = 5 for N-OX). No significant differences were observed. (C) FSH levels during the
four stages of CR (n = 6 for N-MUT; n = 12 for WT; n = 5 for N-OX). Two-way ANOVA
indicated significant genotype (P = 0.022) and CR (P = 0.002) effects but no significant
interaction. (D–F) Estradiol, progesterone, and testosterone levels before and after CR (n = 3
for N-MUT; n = 3 for WT; n = 3 for N-OX. Each sample was pooled from two animals). Two-
way ANOVA indicated significant genotype (P = 0.0004) and CR (P = 0.0033) effects for
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libitum normal chow. This suggested that the overexpression of SIRT1 rendered the mice
more sensitive to the metabolic effects of CR.
In a previous study, deletion of SIRT1 enzyme activity (Dexon 4) in neurons, astrocytes,
glia, and the pituitary, using nestin-cre, disrupted the GH-IGF1 axis, causing runting [43].
Young mice had normal glucose tolerance but older mice were glucose intolerant. CR im-
proved glucose tolerance in WT and the total-brain KO mice, indicating that SIRT1 enzyme
activity was not required for the metabolic response to CR43. These KO mice had increased
physical activity in a wheel-running experiment but did not respond to CR. A subsequent
study showed this activity difference correlated with lower anxiety and increased exploratory
drive due to decreased monoamine oxidase activity and increased serotonin and norepi-
nephrine levels [41]. These studies were confounded, however, by the observation that SIRT1
is essential for neural fate determination in neural stem cells and could alter the final balance
of neuronal, astrocyte, and oligodendrocyte populations, including Npy/AgRP and Pomc
neurons [55–58]. More-focused deletion in specific neuronal populations has produced
conflicting results. Deletion of Sirt1 in either Pomc or Sf1 neurons decreases energy
estradiol, a CR effect (P = 0.0055) for progesterone, and genotype (P = 0.015) and CR (P =
0.019) effects for testosterone. No significant interactions of CR and genotype were observed.
*P , 0.05, **P , 0.01, *P , 0.001, ****P , 0.0001 (post hoc testing). Met, metestrus.
Figure 6. Hypothalamic and pituitary gene expression in N-MUT and N-OX mice. Data for
N-MUT mice are shown in red, in white for WT littermates, and green for N-OX mice in green. (A)
Gene expression in the hypothalami from female mice, determined by qPCR. (B) Gene expression
in the pituitaries from female mice, determined by qPCR. Data are reported as mean 6 SEM; n =
5 for N-MUT; n = 10 for WT, and n = 5 for N-OX. *P , 0.05, **P , 0.01. Rel, relative.
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expenditure and increases susceptibility to diet-induced obesity but has no effect in mice
receiving normal amounts of chow [45, 48]. However, deletion in Agrp neurons has the
opposite effect and decreases food intake and body weight [46, 47]. Transgenic SIRT1
overexpression in Pomc or Sf1 neurons increased energy expenditure, increased insulin
sensitivity, and reduced body weight. The opposite effect was observed when SIRT1 was
overexpressed in the mouse forebrain, using the CMKIIa promoter, which caused decreased
energy expenditure and physical activity, resulting in obesity and glucose intolerance [59].
We did not see an effect on body weight in either the female N-OX or N-MUT mice receiving
normal amounts of chow, similar to the Pomc or Sf1 neuron KOs, but we observed an increase
in physical activity and oxygen consumption in femaleN-OXmice, and our mice were glucose
intolerant. In addition, overexpression of SIRT1 using the mouse prion Prp promoter caused
an enhanced response to CR, as measured by physical activity counts [44], in agreement with
our study findings. These findings confirm the ability of SIRT1 to mediate the central
metabolic effects of CR, but overexpression of SIRT1 alone may not be sufficient to mimic CR.
Figure 7. Metabolic cage assessment of N-OX mice. Data of WT mice (n = 6) are shown in
black and of N-OX mice (n = 6) in green. Graphs show diurnal patterns over 24 h measured
per 13-min interval for the measures indicated by the y-axis labels. Horizontal black bar
indicates period of lights off (6:00 PM to 6:00 AM). (A) Ambulatory activity counts. (B) Rearing
activity counts. (C) VO2 consumption. (D) Respiratory exchange ratio. (E) Food intake. (F)
Water intake. (G) Heat produced. (H) Cage temperature. Data are reported as mean 6 SEM.
In all cases, repeated measures ANOVA indicated a significant time effect (P , 0.0001).
Ambulatory activity, rearing activity, VO2, RER, and water intake were associated with
significant genotype effects (P , 0.0001, P , 0.0001, P , 0.0001, P = 0.0004, and P = 0.04,
respectively). *P , 0.05, **P , 0.01, by post hoc testing. RER, respiratory exchange ratio;
Temp, temperature; VO2, oxygen consumption.
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At the reproductive level, complete loss of Sirt1 results in hypogonadotropic hypogonadism,
due to failure ofGnrh neurons to migrate [28]. Female pubertal development was normal in the
N-OX and N-MUT mice. Overexpression of SIRT1 impaired estrous cycles and increased the
number of days in estrus, perhaps because the N-OX mice did not have the normal increase in
FSH levels during estrus to start the next follicular cycle. LH and progesterone surges were
absent on the evening of proestrus in theN-OXmice, consistent with a defect in ovulation, which
was confirmed by the ovarian histology that showed fewer corpora lutea. These findings are in
agreement with those of a study reporting that the SIRT1 activator SRT1720 reduced ovary size
and the number of corpora lutea [60]. Despite these defects, the mice were still fertile when
mated to WT mice on the day of proestrus, indicating that the mice can respond to normal
pheromonal or environmental cues. When subjected to CR, the N-OX mice went into diestrus
arrest earlier than their littermates, suggesting that the overexpression of SIRT1 also renders
mice more sensitive to the suppression of reproductive cycles. Unlike other fasting studies, LH
levels did not decrease with the gradual CR, indicating that we avoided an adrenal stress
response, which is known to suppress LH.Wenoticed a consistent increase inplasmaFSH levels
during CR in female, but not male, mice, independent of genotype. It is possible that this in-
crease with CR allows the N-OX mice to leave estrus and reenter the estrous cycle before
arresting in the next diestrus. The origin of this increase in FSH levels is not known, but we
observed a significant increase in pituitary Fshb mRNA in the N-OX mice with CR. In-
terestingly, loss of SIRT1 has been implicated in increased Fshb production by pituitary
gonadotropes [61]. We also observed increases in hypothalamicNpy and AgrpmRNAs in theN-
OX mice on CR, which may underlie the effects of CR, because they inhibit GnRH neuronal
suppression of reproductive cycles.
Last, SIRT1 has also been implicated in circadian rhythms in the suprachiasmatic nucleus
(SCN) [54] and in relaying nutritional inputs to the clock via Sf1 neurons in the VMH [62]. The
total-brain SIRT1 KO mice have increased photoperiod, and the SIRT1 overexpressors have
decreased photoperiod, compared withWT controls [54]. In our study, neitherN-OX norN-MUT
mice demonstrated a circadianphenotype, but it is possible that the synapsin-cre is not expressed
in SCN neurons, although synapsin 1 is a reliablemarker for synapse formation in the SCN [63].
Additional studies are needed to resolve this discrepancy.
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